MyFirstApp Sweden AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0020541589
SEK
4.41
-0.58 (-11.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 164 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

-444.23%

stock-summary
Price to Book

49.68

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
194.0%
0%
194.0%
6 Months
225.46%
0%
225.46%
1 Year
539.13%
0%
539.13%
2 Years
206.25%
0%
206.25%
3 Years
3215.79%
0%
3215.79%
4 Years
564.16%
0%
564.16%
5 Years
-96.75%
0%
-96.75%

MyFirstApp Sweden AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.59%
EBIT Growth (5y)
11.61%
EBIT to Interest (avg)
-6.73
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.33
Tax Ratio
2.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
15.89%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
38.83
EV to EBIT
-54.62
EV to EBITDA
-128.03
EV to Capital Employed
39.18
EV to Sales
91.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-71.73%
ROE (Latest)
-444.23%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by MyFirstApp Sweden AB"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 19.05% vs 425.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -178.57% vs -4,300.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.50",
          "val2": "2.10",
          "chgp": "19.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.40",
          "val2": "-2.00",
          "chgp": "80.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "0.10",
          "chgp": "1,100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.70",
          "val2": "-4.20",
          "chgp": "-178.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,724.70%",
          "val2": "-1,826.00%",
          "chgp": "10.13%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2.50
2.10
19.05%
Operating Profit (PBDIT) excl Other Income
-0.40
-2.00
80.00%
Interest
1.20
0.10
1,100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-11.70
-4.20
-178.57%
Operating Profit Margin (Excl OI)
-1,724.70%
-1,826.00%
10.13%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 19.05% vs 425.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -178.57% vs -4,300.00% in Dec 2023

stock-summaryCompany CV
About MyFirstApp Sweden AB stock-summary
stock-summary
MyFirstApp Sweden AB
Pharmaceuticals & Biotechnology
ObsteCare AB is a Sweden-based provider of solutions within area of childbirth care. The Company is a developer of Amniotic Fluid Lactate (AFL) method, which aims to measure lactic acid content in the fetal water. Samples of amniotic fluid are collected and analyzed for the concentration of lactate. The lactate level is automatically presented in the partogram. By combining the result with the development of cervix dilatation a thorough understanding of the delivery status is obtained. The fluid is collected with a standard syringe. The fluid is delivered into the single use measuring probe on the measuring unit and the measurement starts automatically. The method is used by clinics primarily in the Nordic countries, the United Kingdom and the Baltic States.
Company Coordinates stock-summary
Company Details
Fogdevreten 2 , SOLNA None : 171 65
Registrar Details